Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.
|Articles|May 19, 2022
Climate Psychiatry 101
Author(s)Elizabeth Haase, MD
What is the clinical impact of climate psychiatry?
Advertisement
How does heat affect the medications you prescribe for your patients? What impact does ecological distress have on the prevalence of psychiatric symptoms and disorders? Is pollution causing neurobehavioral issues in children and adolescents?
Join Psychiatric TimesTM Climate Change Section Editor Elizabeth Haase, MD, and colleagues John W. Sullenbarger, MD; Peter L. Chien, MD; and Emily Margaret Schutzenhofer, MD, for “
Advertisement
Related to this article
Antipsychotic levels clarify adherence, guide dose escalation up to a point of futility, and offer more than pharmacogenetic testing, says Jonathan Meyer, MD.
Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.
How to interpret antipsychotic drug levels in schizophrenia: when labs mislead, when levels help adherence and toxicity checks, and why serial monitoring matters.
Male athletes with anorexia often go unnoticed as “discipline”; learn red flags, sport-specific risks, health consequences, and treatment steps for earlier diagnosis.
Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
Therapeutic drug monitoring takes guesswork out of antipsychotic care—spotting nonadherence, guiding dose targets, and defining response thresholds and the “point of futility” in schizophrenia.
A psychiatric NP shares mentorship lessons, training fixes, and her Psych NP Boot Camp—plus practical tips to close prescriber gaps and improve team-based care.
Advertisement
Advertisement
Trending on Psychiatric Times
1
How Best to Manage Treatment-Resistant Depression
2
Anorexia Nervosa in Male Athletes: Clinical Recognition and Diagnostic Challenges
3
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
4
Choosing an Antidepressant: Art, Science, and Knowing Your Patient
5